Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 196

Related Citations for PubMed (Select 812614)

1.

Vasodilator therapy for chronic left ventricular failure.

Kovick RB, Tillisch JH, Berens SC, Bramowitz AD, Shine KI.

Circulation. 1976 Feb;53(2):322-8.

PMID:
812614
2.
3.

Combination vasodilator therapy for severe chronic congestive heart failure.

Chatterjee K, Drew D, Parmley WW, Klausner SC, Polansky J, Zacherle B.

Ann Intern Med. 1976 Oct;85(4):467-70.

PMID:
823852
4.

Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.

Gray R, Chatterjee K, Vyden JK, Ganz W, Forrester JS, Swan HJ.

Am Heart J. 1975 Sep;90(3):346-52.

PMID:
1163426
5.

Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.

Mantle JA, Russell RO Jr, Moraski RE, Rackley CE.

Am J Cardiol. 1976 Feb;37(2):263-8. Review.

PMID:
1108634
6.

Results of long-term vasodilator therapy in patients with refractory congestive heart failure.

Walsh WF, Greenberg BH.

Circulation. 1981 Sep;64(3):499-505.

PMID:
7261282
7.

Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.

Kodama K, Koretsune Y, Nanto S, Taniura K.

Jpn Circ J. 1984 Apr;48(4):380-7.

PMID:
6425527
8.
9.

[Vasodilator therapy of congestive heart failure].

Schröder R.

Dtsch Med Wochenschr. 1977 Sep 30;102(39):1388-94. Review. German. No abstract available.

PMID:
410617
10.

Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.

Massie B, Chatterjee K, Werner J, Greenberg B, Hart R, Parmley WW.

Am J Cardiol. 1977 Nov;40(5):794-801.

PMID:
411364
12.

Isosorbide dinitrate in acute and chronic heart failure.

Venkataraman K, Durairaj SK, de Guzman M, Haywood LJ.

Clin Pharmacol Ther. 1979 Jan;25(1):43-50.

PMID:
758242
13.

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, et al.

N Engl J Med. 1986 Jun 12;314(24):1547-52.

14.

Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.

Packer M, Medina N, Yushak M, Lee WH.

Am J Cardiol. 1986 Feb 1;57(4):260-7.

PMID:
3080861
15.

Regression of myocardial cellular hypertrophy with vasodilator therapy in chronic congestive heart failure associated with idiopathic dilated cardiomyopathy.

Unverferth DV, Mehegan JP, Magorien RD, Unverferth BJ, Leier CV.

Am J Cardiol. 1983 May 1;51(8):1392-8.

PMID:
6682617
16.

Hemodynamic effects of isosorbide dinitrate vs nitroglycerin in patients with unstable angina.

Willis WH Jr, Russell RO Jr, Mantle JA, Ratshin RA, Rackley CE.

Chest. 1976 Jan;69(1):15-22.

PMID:
811427
17.
18.

Importance of venodilation during long-term vasodilator therapy of chronic left ventricular failure.

Franciosa JA, Leddy CL, Schwartz DE.

Z Kardiol. 1983;72 Suppl 3:168-72.

PMID:
6666217
19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk